Literature DB >> 12517771

Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.

Jae Wan Lee1, Steven M Yannone, David J Chen, Lawrence F Povirk.   

Abstract

In the nonhomologous end joining pathway of DNA double-strand break repair, the ligation step is catalyzed by a complex of XRCC4 and DNA ligase IV. Extracts of CHO-K1 cells are able to accurately rejoin a site-specific free radical-mediated double-strand break with partially complementary overhangs, by a mechanism involving alignment-based gap filling followed by ligation. Extracts of XR-1 cells, which lack XRCC4 and DNA ligase IV, carried out neither gap filling nor ligation. Supplementation of the extracts with recombinant XRCC4/ligase IV, but not with XRCC4 alone, restored gap filling and accurate end joining. The results imply that XRCC4 and ligase IV are essential for alignment-based gap filling, as well as for final ligation of the breaks.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12517771

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Base damage immediately upstream from double-strand break ends is a more severe impediment to nonhomologous end joining than blocked 3'-termini.

Authors:  Kamal Datta; Shubhadeep Purkayastha; Ronald D Neumann; Elzbieta Pastwa; Thomas A Winters
Journal:  Radiat Res       Date:  2011-01       Impact factor: 2.841

2.  End-joining repair of double-strand breaks in Drosophila melanogaster is largely DNA ligase IV independent.

Authors:  Mitch McVey; Dora Radut; Jeff J Sekelsky
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

3.  Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4.

Authors:  Peï-Yu Wu; Philippe Frit; SriLakshmi Meesala; Stéphanie Dauvillier; Mauro Modesti; Sara N Andres; Ying Huang; JoAnn Sekiguchi; Patrick Calsou; Bernard Salles; Murray S Junop
Journal:  Mol Cell Biol       Date:  2009-03-30       Impact factor: 4.272

4.  Requirement for XLF/Cernunnos in alignment-based gap filling by DNA polymerases lambda and mu for nonhomologous end joining in human whole-cell extracts.

Authors:  Konstantin Akopiants; Rui-Zhe Zhou; Susovan Mohapatra; Kristoffer Valerie; Susan P Lees-Miller; Kyung-Jong Lee; David J Chen; Patrick Revy; Jean-Pierre de Villartay; Lawrence F Povirk
Journal:  Nucleic Acids Res       Date:  2009-05-06       Impact factor: 16.971

5.  Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions.

Authors:  Amy Marie Yu; Mitch McVey
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 19.160

6.  Two-Stage Synapsis of DNA Ends during Non-homologous End Joining.

Authors:  Thomas G W Graham; Johannes C Walter; Joseph J Loparo
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

7.  Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.

Authors:  L W M Loo; C Ton; Y-W Wang; D I Grove; H Bouzek; N Vartanian; M-G Lin; X Yuan; T L Lawton; J R Daling; K E Malone; C I Li; L Hsu; P L Porter
Journal:  Genes Chromosomes Cancer       Date:  2008-12       Impact factor: 5.006

8.  Unstabilized DNA breaks in HTLV-1 Tax expressing cells correlate with functional targeting of Ku80, not PKcs, XRCC4, or H2AX.

Authors:  Franca Majone; Kuan-Teh Jeang
Journal:  Cell Biosci       Date:  2012-04-27       Impact factor: 7.133

9.  A noncatalytic function of the ligation complex during nonhomologous end joining.

Authors:  Jessica Cottarel; Philippe Frit; Oriane Bombarde; Bernard Salles; Aurélie Négrel; Stéphanie Bernard; Penny A Jeggo; Michael R Lieber; Mauro Modesti; Patrick Calsou
Journal:  J Cell Biol       Date:  2013-01-21       Impact factor: 10.539

10.  Expression of DNA-PKcs and BRCA1 as prognostic indicators in nasopharyngeal carcinoma following intensity-modulated radiation therapy.

Authors:  Jiao Yang; Ximing Xu; Yanrong Hao; Jiaxin Chen; Heming Lu; Jian Qin; Luxing Peng; Biao Chen
Journal:  Oncol Lett       Date:  2013-02-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.